Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1989;82(Suppl 17):30–34.

Toxicity of antimalarial drugs.

T E Peto 1
PMCID: PMC1291935  PMID: 2693722

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein H. N. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy. Am J Med. 1983 Jul 18;75(1A):25–34. doi: 10.1016/0002-9343(83)91267-6. [DOI] [PubMed] [Google Scholar]
  2. Centers for Disease Control (CDC) Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. MMWR Morb Mortal Wkly Rep. 1985 Apr 12;34(14):185-90, 195. [PubMed] [Google Scholar]
  3. Cook G. C. Plasmodium falciparum infection: problems in prophylaxis and treatment in 1986. Q J Med. 1986 Dec;61(236):1091–1115. [PubMed] [Google Scholar]
  4. Daniels A. M. Mouth ulceration associated with proguanil. Lancet. 1986 Feb 1;1(8475):269–269. doi: 10.1016/s0140-6736(86)90799-3. [DOI] [PubMed] [Google Scholar]
  5. Davidson N. M. Mouth ulceration associated with proguanil. Lancet. 1986 Feb 15;1(8477):384–384. doi: 10.1016/s0140-6736(86)92347-0. [DOI] [PubMed] [Google Scholar]
  6. Doxycycline prophylaxis in malaria. Lancet. 1987 Jun 27;1(8548):1487–1487. [PubMed] [Google Scholar]
  7. Fogh S., Schapira A., Bygbjerg I. C., Jepsen S., Mordhorst C. H., Kuijlen K., Ravn P., Rønn A., Gøtzsche P. C. Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine. Br Med J (Clin Res Ed) 1988 Mar 19;296(6625):820–822. doi: 10.1136/bmj.296.6625.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hanson S. N., Kuylen K., Björkman A. B. Hairloss and scaling with proguanil. Lancet. 1989 Jan 28;1(8631):225–225. doi: 10.1016/s0140-6736(89)91246-4. [DOI] [PubMed] [Google Scholar]
  9. Harries A. D., Forshaw C. J., Friend H. M. Malaria prophylaxis amongst British residents of Lilongwe and Kasungu districts, Malawi. Trans R Soc Trop Med Hyg. 1988;82(5):690–692. doi: 10.1016/0035-9203(88)90200-3. [DOI] [PubMed] [Google Scholar]
  10. Hatton C. S., Peto T. E., Bunch C., Pasvol G., Russell S. J., Singer C. R., Edwards G., Winstanley P. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet. 1986 Feb 22;1(8478):411–414. doi: 10.1016/s0140-6736(86)92371-8. [DOI] [PubMed] [Google Scholar]
  11. Hernborg A. Stevens-Johnson syndrome after mass prophylaxis with sulfadoxine for cholera in Mozambique. Lancet. 1985 Nov 9;2(8463):1072–1073. doi: 10.1016/s0140-6736(85)90945-6. [DOI] [PubMed] [Google Scholar]
  12. Kelsey J. H. Prolonged malaria prophylaxis. Br Med J. 1977 Nov 26;2(6099):1415–1415. doi: 10.1136/bmj.2.6099.1415-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Limsomwong N., Pang L. W., Singharaj P. Malaria prophylaxis with proguanil in children living in a malaria-endemic area. Am J Trop Med Hyg. 1988 Mar;38(2):231–236. doi: 10.4269/ajtmh.1988.38.231. [DOI] [PubMed] [Google Scholar]
  14. Mulley G. Letter: Proguanil and mouth ulcers. Lancet. 1974 Jul 20;2(7873):177–177. doi: 10.1016/s0140-6736(74)91626-2. [DOI] [PubMed] [Google Scholar]
  15. Ognibene A. J. Agranulocytosis due to dapsone. Ann Intern Med. 1970 Apr;72(4):521–524. doi: 10.7326/0003-4819-72-4-521. [DOI] [PubMed] [Google Scholar]
  16. Olsen T. G. Chloroquine and psoriasis. Ann Intern Med. 1981 Apr;94(4 Pt 1):546–547. doi: 10.7326/0003-4819-94-4-546_2. [DOI] [PubMed] [Google Scholar]
  17. Pang L. W., Limsomwong N., Boudreau E. F., Singharaj P. Doxycycline prophylaxis for falciparum malaria. Lancet. 1987 May 23;1(8543):1161–1164. doi: 10.1016/s0140-6736(87)92141-6. [DOI] [PubMed] [Google Scholar]
  18. Pang L., Limsomwong N., Singharaj P. Prophylactic treatment of vivax and falciparum malaria with low-dose doxycycline. J Infect Dis. 1988 Nov;158(5):1124–1127. doi: 10.1093/infdis/158.5.1124. [DOI] [PubMed] [Google Scholar]
  19. Peto T. E., Gilks C. F. Strategies for the prevention of malaria in travellers: comparison of drug regimens by means of risk-benefit analysis. Lancet. 1986 May 31;1(8492):1256–1261. doi: 10.1016/s0140-6736(86)91395-4. [DOI] [PubMed] [Google Scholar]
  20. Rieckmann K. H. Tetracycline prophylaxis for malaria. Lancet. 1987 Aug 29;2(8557):507–508. doi: 10.1016/s0140-6736(87)91811-3. [DOI] [PubMed] [Google Scholar]
  21. Rouveix B., Bricaire F., Michon C., Franssen G., Lebras J., Bernard J., Ajana F., Vienne J. L. Mefloquine and an acute brain syndrome. Ann Intern Med. 1989 Apr 1;110(7):577–578. doi: 10.7326/0003-4819-110-7-577. [DOI] [PubMed] [Google Scholar]
  22. Spencer H. C., Poulter N. R., Lury J. D., Poulter C. J. Chloroquine-associated pruritus in a European. Br Med J (Clin Res Ed) 1982 Dec 11;285(6356):1703–1704. doi: 10.1136/bmj.285.6356.1703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Steffen R., Somaini B. Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland. Lancet. 1986 Mar 15;1(8481):610–610. doi: 10.1016/s0140-6736(86)92825-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES